Results 191 to 200 of about 60,175,050 (353)

Evaluating the essential microminerals in chicken and beef from Java, Indonesia using neutron activation analysis for nutritional assessment. [PDF]

open access: yesSci Rep
Lestiani DD   +8 more
europepmc   +1 more source

The Moss Biomonitoring Method and Neutron Activation Analysis in Assessing Pollution by Trace Elements in Selected Polish National Parks. [PDF]

open access: yesArch Environ Contam Toxicol, 2020
Kosior G   +5 more
europepmc   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Measurement of sodium in soft tissue and bone in a sodium diet intervention study using<i>in vivo</i>neutron activation analysis. [PDF]

open access: yesPhysiol Meas
Yue S   +9 more
europepmc   +1 more source

Correspondence of the brain's functional architecture during activation and rest

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2009
Stephen M. Smith   +10 more
semanticscholar   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

E.PathDash, pathway activation analysis of publicly available pathogen gene expression data. [PDF]

open access: yesmSystems
Taub L   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy